Dr Richard Charles Gregorin Ii, DDS | |
6901 E Tudor Rd, Suite #9, Anchorage, AK 99507-1241 | |
(907) 333-5522 | |
(907) 333-5707 |
Full Name | Dr Richard Charles Gregorin Ii |
---|---|
Gender | Male |
Speciality | Dentist |
Location | 6901 E Tudor Rd, Anchorage, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588873384 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 1034 (Alaska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Richard Charles Gregorin Ii, DDS 6105 Eastwood Ct, Anchorage, AK 99504-4430 Ph: (907) 333-2061 | Dr Richard Charles Gregorin Ii, DDS 6901 E Tudor Rd, Suite #9, Anchorage, AK 99507-1241 Ph: (907) 333-5522 |
News Archive
Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.
Baxter International Inc. announced today that it has submitted an application to the European Medicines Agency's Committee for Human Medicinal Products seeking marketing authorization for HyQ. HyQ is Baxter's investigational immunoglobulin (IG) therapy administered subcutaneously and facilitated by recombinant human hyaluronidase, a dispersion and permeation enhancer, for use in patients with primary immunodeficiencies.
In a new study, researchers show that engineered nanosponges that are encapsulated in the membranes of red blood cells can reduce the severity of infections caused by group A Streptococcus, the bacteria responsible for strep throat and life-threatening infections such as necrotizing fasciitis, or flesh-eating disease.
In a new study published in npj Digital Medicine, a team led by Child Mind Institute researchers report that a wearable tracking device they developed achieves higher accuracy in position tracking using thermal sensors in addition to inertial measurement and proximity sensors.
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC).
› Verified 7 days ago
Dr. David Lynn Maisey, DDS Dentist Medicare: Medicare Enrolled Practice Location: 3401 Denali St, Ste. 102, Anchorage, AK 99503 Phone: 907-561-1317 | |
Justin Erickson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4001 Lake Otis Pkwy, #200, Anchorage, AK 99508 Phone: 907-222-0400 | |
Dr. Thomas Nelson Wanat Iii, D.M.D., M.S. Dentist Medicare: Medicare Enrolled Practice Location: 4501 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1729 | |
Dr. Max W. Swenson, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2600 Cordova St Ste 200, Anchorage, AK 99503 Phone: 907-276-1712 Fax: 907-258-4482 | |
Dr. Michael Ogden Madsen, DDS Dentist Medicare: Medicare Enrolled Practice Location: 4951 Business Park Blvd, Anchorage, AK 99503 Phone: 907-743-7202 | |
Dr. Paige Sthen Ryan, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1310 E Dimond Blvd Ste 3, Anchorage, AK 99515 Phone: 907-336-7337 Fax: 907-336-7338 | |
James Singleton, DDS Dentist Medicare: Medicare Enrolled Practice Location: 4201 Tudor Centre Dr, Suite 320, Anchorage, AK 99508 Phone: 907-317-6070 Fax: 806-794-1919 |